Keyphrases
Tuberculosis
100%
Cost-effectiveness
83%
Typhoid Vaccine
70%
Tuberculosis Treatment
70%
India
62%
Vaccine Introduction
51%
Household Contacts
47%
Public Health Impact
47%
Modeling Analysis
47%
South Africa
43%
Prison
39%
Bangladesh
39%
Tuberculosis Preventive Treatment
35%
Standard of Care
35%
Rifampin
35%
Tuberculosis Patients
35%
AIDS/HIV
34%
High Prevalence
31%
Tuberculosis Regimen
31%
Catch-up Campaign
29%
Routine Vaccination
27%
High Incidence
27%
Treatment Regimen
26%
Low-income Countries
26%
Room Occupancy
26%
Centers for Disease Control
26%
State Prison
26%
Disease Prevention
26%
Disability-adjusted Life Years
25%
Incremental Cost-effectiveness Ratio
25%
Vaccination
24%
Rifampicin-resistant Tuberculosis
24%
COVID-19 Risk
23%
Preventive Treatment
23%
Short Course
23%
Low-income
23%
HIV Infection
23%
Feed the Future
23%
Funding Gap
23%
Mathematical Model Analysis
23%
Person-centered
23%
Funding Constraints
23%
National Government
23%
Upper-middle Income Countries
23%
Development Assistance
23%
Green Liver
23%
Financial Agreements
23%
Bayesian Modeling
23%
COVID-19
23%
Resource Tracking
23%
Medicine and Dentistry
Cost-Effectiveness Analysis
95%
Health Care Cost
90%
Conjugate Vaccine
73%
COVID-19
59%
Disease
55%
Public Health
50%
Case Finding
47%
Tuberculosis Treatment
47%
Infection
41%
Typhoid Fever
38%
Symptom
33%
Disability Adjusted Life Years
31%
Prevalence
28%
Rifampicin
25%
Post-COVID-19
23%
Childbirth
23%
Health Disparity
23%
Weakness
23%
Observational Study
23%
Prophylaxis
23%
Human Immunodeficiency Virus
23%
Household
23%
Antibiotic Resistance
15%
Health System
13%
Determinants of Health
11%
Typhoid Vaccine
11%
HIV/AIDS
11%
Non-Pharmaceutical Intervention
10%
Drug Sensitivity
7%
Drug Resistant Tuberculosis
7%
Incarcerated Population
5%
Head
5%
Hazard Ratio
5%
Cost of Illness
5%
